SEC EDGAR · Company announcement
ENTG: Leadership change
Filed 8-K for an event or period dated 2026-07-28. Leadership change.
Follow ENTG- Became public
- Jul 29, 2026, 5:08 PM EDT
- Event / period date
- Jul 28, 2026
- Collected
- Nov 9, 2026, 2:16 PM EST
Why this is connected
This filing identifies ENTEGRIS INC as the issuer of the security. The company's SEC identifier connects it to ENTG.
Press Release, dated July 29, 2026 ↗Source evidence
Read the source excerpt or record
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 28, 2026, Bertrand Loy, Executive Chair of the Board of Directors (the "Board") of Entegris, Inc. (the "Company"), notified the Board that he will retire from his employment with the Company as Executive Chair effective July 31, 2026 upon the expiration of the Executive Chair Agreement, dated July 30, 2025 (the "Executive Chair Agreement), by and between the Company and Mr. Loy (filed as Exhibit 10.2 to the Form 10-Q for the quarterly period ended June 28, 2025). Mr. Loy has also notified the Board that he will resign as a member of the Board, also effective on July 31, 2026. Mr. Loy's decision to retire and resign from the Board is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Mr. Loy's outstanding equity awards and his 2026 annual incentive opportunity will be treated in accordance with the terms of the Executive Chair Agreement, and the Company has not entered into any new compensatory arrangement with Mr. Loy in connection with his retirement from the Company or from the Board. In connection with Mr. Loy's retirement, the Company announced that the Board has appointed James F. Gentilcore, the current Lead Independent Director of the Board, to serve as Chair of the Board, effective July 31, 2026. On July 29, 2026, the Company also announced that the Board has appointed Robert A. Bruggeworth, president and chief executive officer of Qorvo, Inc., as a director of the Company, effective August 3, 2026 to fill the vacancy created by Mr. Loy's retirement and to serve until the expiration of his predecessor's term at the 2027 annua
Price change after we could observe it
+11.29% ENTG
Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.
Congressional trading in ENTG
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Sep 9, 2026$100K–$250K
Rep. April McClain Delaney (D-MD-6)
$100K–$250K · Traded Aug 25, 2026 · disclosed Sep 9, 2026 · Dependent
Committee overlap: Science - Aug 3, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Jul 30, 2026 · disclosed Aug 3, 2026 · Dependent
Committee overlap: ScienceTraded 5 days before earnings - Aug 3, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Jul 8, 2026 · disclosed Aug 3, 2026 · Dependent
Committee overlap: Science - Jul 7, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Jun 8, 2026 · disclosed Jul 7, 2026 · Dependent
Committee overlap: Science - Jul 7, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Jun 5, 2026 · disclosed Jul 7, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 21, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 8, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science - Jun 5, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded May 7, 2026 · disclosed Jun 5, 2026 · Dependent
Committee overlap: Science
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.